Navigation Links
Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
Date:10/31/2012

rom the blood. Moreover, traditional LDL-lowering therapies such as statins actually stimulate the production of PCSK9, which limits their own ability to lower LDL-C.  Inhibiting the PCSK9 pathway is therefore a potentially novel mechanism for lowering LDL-C.

About SAR236553/REGN727 and the Phase 2 Program
SAR236553/REGN727, created using Regeneron's VelocImmune® technology, is a fully human monoclonal antibody directed against PCSK9, administered via subcutaneous injection.  By inhibiting PCSK9, a determinant of circulating LDL-C levels in the blood, SAR236553/REGN727 increases the number of free LDL receptors which can clear circulating LDL-C from the bloodstream.

SAR236553/REGN727 has been studied in three Phase 2 clinical studies: Two dose ranging studies in patients with hypercholesterolemia; one with 183-patients, and another with 92-patients, and one study of 77 patients with heterozygous familial hypercholesterolemia (heFH).  In the primary hypercholesterolemia trials treatment with different dose regimens of SAR236553/REGN727 on top of statin therapy significantly reduced LDL-C from baseline by 40% to 72% over the 8 or 12-week treatment period.  A third Phase 2 study was in patients with heFH whose LDL-C levels remained elevated despite statin therapy with or without ezetimibe.  Across the four tested doses of SAR236553/REGN727 administered for up to 12 weeks, patients achieved a mean reduction in LDL-C from baseline of 28% to 68%.  In the Phase 2 program, injection site reactions were the most common adverse events with SAR236553/REGN727.  Rare cases of hypersensitivity reaction were also reported.  There were five serious adverse events (SAE) in the active treatment arms (1.8%, 5/275) and two SAEs in the placebo groups (2.6%, 2/77).

About Regeneron Pharmaceuticals
Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteur to add 2D barcode to six more vaccines
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
4. BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals
5. Regeneron Named Worlds #1 Biopharmaceutical Employer in Science Magazine Annual Survey
6. Regeneron Announces September 2012 Investor Conference Presentations
7. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
8. Regeneron Announces June 2012 Investor Conference Presentations
9. Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
10. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
11. BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014   MedeAnalytics ... solution that brings complete visibility to a provider,s ... an ever-evolving reimbursement landscape. Powered by the industry,s ... to the critical point between patient access and ... The solution will improve revenue capture, minimize audit ...
(Date:9/17/2014)... , Sept. 17, 2014  The law ... today announced that it will serve as host ... and Avoiding the Risks of Healthcare Reform," a ... will examine delivery systems, reimbursement, compliance and enforcement ... Act. Logo -  http://photos.prnewswire.com/prnh/20140916/146606 ...
(Date:9/17/2014)... , Sept. 17, 2014 Cardiac Dimensions ... data from the TITAN II clinical trial of ... and sustained improvements in mitral regurgitation, functional improvement, ... long-term safety and efficacy data, which was consistent ... Sept. 13 at the 26 th annual ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 2Cardiac Dimensions Announces New Long-Term Outcomes Data From TITAN II Clinical Trial Demonstrates Safety, Efficacy Of Enhanced CARILLON Mitral Contour System 3
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... Conference on Friday, October 22, 2010 at 3:00 pm ... New York. A live webcast of ...
... Network, already the largest distributor of FDA-approved drug ... that this month it will surpass six million ... ("REMS") program alerts delivered to prescribers. FDA-approved Drug-Alerts ... Network,s Health Care Notification Network (HCNN) service since ...
Cached Medicine Technology:PDR Network Delivers Six Million Drug Alerts & REMS 2PDR Network Delivers Six Million Drug Alerts & REMS 3
(Date:9/17/2014)... Phoenix, Arizona (PRWEB) September 17, 2014 ... valuable option for children who cannot live with their ... is necessary to continue to enhance services and supports ... League of America’s (CWLA) National Kinship Care Conference is ... field’s collective knowledge of best practice, policy, program and ...
(Date:9/17/2014)... City, UT (PRWEB) September 17, 2014 ... America 2015 Kira Kazantsev and ushered in a ... charitable support. As Miss America Organization’s official national ... welcoming Kazantsev as its newest National Goodwill Ambassador. ... at member Children’s Miracle Network Hospitals across the ...
(Date:9/17/2014)... spaceflight has been reserved for the very healthy. ... the highest physical and psychological standards to prepare ... advent of commercial spaceflight, average people can now ... had very little information about what medical conditions ... the spaceflight environment, as most medical conditions have ...
(Date:9/17/2014)... research study was announced today that will analyze ... long-term wellness and contribute to healthy aging. ... and funded through a $10 million unrestricted gift ... WELL aims to identify lifestyle and environmental factors ... wellness as they age. WELL will be designed, ...
(Date:9/17/2014)... struggle to distinguish between a business strategy and business plan, ... answer by reading Per Wickstrom’s latest blog post. , “The ... and a business strategy are both strategic – and what’s ... view it is that a business plan is part one, ... , According to the blog post, a business plan is ...
Breaking Medicine News(10 mins):Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 2Health News:Miss America 2015 Kira Kazantsev Takes On Role as Children’s Miracle Network Hospitals National Goodwill Ambassador 3Health News:Space: The final frontier… open to the public 2Health News:First-ever research study examines impacts of diet and lifestyle on healthy aging 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2
... Huntington,s disease may give patients hope for a cure. ... tissue of Huntington,s disease patients determined that an overactive ... cells to die. Toning down the activity of that ... kept those cells alive, according to the research team ...
... medical literature on cannabis use and sexual health has ... performance. "Cannabis is the most widely-used illicit drug ... Department of Pharmacology and Toxicology. "It is also often ... of the hazardous effects it may be having on ...
... the brain may need a new name, say scientists who ... finding, published in PLoS One , may help explain ... of surviving it, according to scientists at Georgia Health Sciences ... off a building or just the thought of either ...
... Jerusalem, February 22, 2011 -- The portion of the brain ... to a new study by researchers from the Hebrew University ... blind people as they read words in Braille show activity ... up when sighted readers read. The findings challenge the textbook ...
... consecutive year, Women & Infants Hospital of Rhode Island ... Care by the Clinical Sciences Institute of OptumHealth, an ... health care providers are created equal. For complex ... a rigorous evaluation process, OptumHealth developed Centers of Excellence ...
... herald the onset of major depression and the associated ... Research that focuses on access to treatment for adolescents ... persistent disparities based on race and ethnicity. Unfortunately such ... across all individuals and communities has yet to be ...
Cached Medicine News:Health News:Huntington's disease breakthrough equals hope for patients 2Health News:Brain's 'reward' center also responds to bad experiences 2Health News:Brain doesn't need vision at all in order to 'read' material 2Health News:Brain doesn't need vision at all in order to 'read' material 3Health News:Women & Infants named Center of Excellence for Neonatal Care for fifth year 2Health News:Racial and ethnic minority adolescents less likely to receive treatment for major depression 2
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches....
Straight shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches....
Curved shafts with 12 mm tying platform. Serrated handle with polished finish. Overall length 4.3 inches....
Hartman Mosquito forceps, straight, 3-1/2", German stainless steel...
Medicine Products: